Results 251 to 260 of about 3,602,430 (295)
Some of the next articles are maybe not open access.

The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies

Expert opinion on therapeutic targets, 2016
S. Su   +4 more
semanticscholar   +1 more source

Plasminogen Activators and Plasminogen Activator Inhibitors in Neural Developmenta

Annals of the New York Academy of Sciences, 1992
N W, Seeds   +9 more
openaire   +2 more sources

t-Plasminogen Activator

2013
Lijnen, HR, Rijken, Dick
openaire   +2 more sources

PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION

The Lancet, 1987
A. Hamsten   +7 more
semanticscholar   +1 more source

ACTIVATION OF PLASMINOGEN

Annals of the New York Academy of Sciences, 1957
openaire   +2 more sources

Involvement of Urokinase‐Type Plasminogen Activator System in Cancer: An Overview

Medicinal research reviews (Print), 2014
Ahmed H. Mekkawy   +2 more
semanticscholar   +1 more source

u-Plasminogen activator

1998
Dietmar Schomburg, Dörte Stephan
openaire   +1 more source

Plasminogen Activating System

2008
Salvatore Ulisse   +3 more
openaire   +1 more source

Plasminogen activators and plasminogen activator inhibitors: biochemical aspects.

Bailliere's clinical haematology, 1995
Although this chapter does not represent a historical review, it will be clear how the biochemistry of t-PA, u-PA, PAI-1 and PAI-2 has evolved and where we stand in 1994. While the functional activities of the proteins were recognized at least three to four decades ago, highly purified preparations became available around 1980.
openaire   +1 more source

Home - About - Disclaimer - Privacy